Upcoming trial - Psilocybin for major depression: A randomised control trial
Psilocybin for major depression: A randomised control trial - the design of this trial is a DB-RCT in major depressive disorder. We will use fMRI to compare the treatment mechanisms of six weeks of daily escitalopram with one single dose of psilocybin. The trial will start in 2018. Please enquire about eligibility for this study by emailing Bruna Giribaldi b.cunha@imperial.ac.uk
We will also be recruiting healthy volunteers who have never taken a psychedelic for a separate psilocybin fMRI study beginning in 2018. Please enquire about this by emailing Taylor Lyons t.lyons15@imperial.ac.uk
Psilocybin for major depression: A randomised control trial - the design of this trial is a DB-RCT in major depressive disorder. We will use fMRI to compare the treatment mechanisms of six weeks of daily escitalopram with one single dose of psilocybin. The trial will start in 2018. Please enquire about eligibility for this study by emailing Bruna Giribaldi b.cunha@imperial.ac.uk
We will also be recruiting healthy volunteers who have never taken a psychedelic for a separate psilocybin fMRI study beginning in 2018. Please enquire about this by emailing Taylor Lyons t.lyons15@imperial.ac.uk